Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50

Galderma logo

Galderma

Status

Completed

Conditions

Skin Irritation

Treatments

Other: Cetaphil Daily Facial Moisturizer SPF 50

Study type

Interventional

Funder types

Industry

Identifiers

NCT01887860
GLI.04.SRE.US10232c

Details and patient eligibility

About

Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Not currently under a doctor's care
  • Free of dermatological or systemic disorder which would interfere with the results
  • Free of any acute or chronic disease
  • Will complete a preliminary medical history form and are in general good health
  • Can read, understand, and sign informed consent

Exclusion criteria

  • Under 18 years old
  • Currently under doctor's care
  • Currently taking any medication
  • History of acute or chronic disease
  • Diagnosed with chronic skin allergies
  • Pregnant or lactating

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Cetaphil Daily Facial Moisturizer SPF50
Experimental group
Description:
All subjects receive Cetaphil Daily Facial Moisturizer SPF 50
Treatment:
Other: Cetaphil Daily Facial Moisturizer SPF 50

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems